Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Rheumatology

Other Arthritis

Long‐term outcome of patients with palindromic rheumatism treated with methotrexate

International Journal of Rheumatic Diseases | Feb 11, 2022 Other Arthritis

Human herpesvirus infections and circulating macrovesicles expressing galectin-3 binding protein in patients with systemic lupus erythematosus

Clinical &Experimental Rheumatology Online | Feb 02, 2022 Other Arthritis

Cannabidiol (CBD) use among children with juvenile idiopathic arthritis

Pediatric Rheumatology | Dec 17, 2021 Other Arthritis

Impact of the season of birth on the development of juvenile idiopathic arthritis in the United States: A nationwide registry-based study

The Journal of Rheumatology | Dec 05, 2021 Other Arthritis

Tofacitinib in juvenile idiopathic arthritis: A double-blind, placebo-controlled, withdrawal phase 3 randomised trial

The Lancet | Dec 02, 2021 Other Arthritis

Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomized, double-blind, phase 3 KEEPsAKE 2 trial

Annals of Rheumatic Diseases | Nov 26, 2021 Other Arthritis

All‐cause and cause‐specific mortality in psoriatic arthritis and ankylosing spondylitis: A systematic review and meta‐analysis

Arthritis Care & Research | Nov 22, 2021 Other Arthritis

Vitamin D levels and risk of juvenile idiopathic arthritis: A Mendelian randomization study

Arthritis Care & Research | Nov 18, 2021 Other Arthritis

Tofacitinib in juvenile idiopathic arthritis: A double-blind, placebo-controlled, withdrawal phase 3 randomised trial

The Lancet | Nov 13, 2021 Other Arthritis

Risk factors of impaired humoral response to COVID-19 vaccination in rituximab treated patients

Rheumatology | Nov 06, 2021 Other Arthritis

« Prev 1 2 3 4 5 … 43 Next »

Long‐term outcome of patients with palindromic rheumatism treated with methotrexate

Human herpesvirus infections and circulating macrovesicles expressing galectin-3 binding protein in patients with systemic lupus erythematosus

Cannabidiol (CBD) use among children with juvenile idiopathic arthritis

Impact of the season of birth on the development of juvenile idiopathic arthritis in the United States: A nationwide registry-based study

Tofacitinib in juvenile idiopathic arthritis: A double-blind, placebo-controlled, withdrawal phase 3 randomised trial

Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomized, double-blind, phase 3 KEEPsAKE 2 trial

All‐cause and cause‐specific mortality in psoriatic arthritis and ankylosing spondylitis: A systematic review and meta‐analysis

Vitamin D levels and risk of juvenile idiopathic arthritis: A Mendelian randomization study

Tofacitinib in juvenile idiopathic arthritis: A double-blind, placebo-controlled, withdrawal phase 3 randomised trial

Risk factors of impaired humoral response to COVID-19 vaccination in rituximab treated patients

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Pulmonary Embolism: MCQs Challenge

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

Top Foods to Combat Winter Illness

Long‐term outcome of patients with palindromic rheumatism treated with methotrexate

Human herpesvirus infections and circulating macrovesicles expressing galectin-3 binding protein in patients with systemic lupus erythematosus

Cannabidiol (CBD) use among children with juvenile idiopathic arthritis

Impact of the season of birth on the development of juvenile idiopathic arthritis in the United States: A nationwide registry-based study

Tofacitinib in juvenile idiopathic arthritis: A double-blind, placebo-controlled, withdrawal phase 3 randomised trial

Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomized, double-blind, phase 3 KEEPsAKE 2 trial

All‐cause and cause‐specific mortality in psoriatic arthritis and ankylosing spondylitis: A systematic review and meta‐analysis

Vitamin D levels and risk of juvenile idiopathic arthritis: A Mendelian randomization study

Tofacitinib in juvenile idiopathic arthritis: A double-blind, placebo-controlled, withdrawal phase 3 randomised trial

Risk factors of impaired humoral response to COVID-19 vaccination in rituximab treated patients

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Pulmonary Embolism: MCQs Challenge

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

Top Foods to Combat Winter Illness

Select Specialty

Select Topic